Photo: Getty Images
March 23, 2026 — Samsung Medison hsa announced that its U.S. medical imaging businesses, previously operating as Neurologica and Boston Imaging, will unify under a new corporate identity, Samsung HME (Healthcare and Medical Equipment) America. This transition brings the company’s U.S. ultrasound, digital radiography and computed tomography (CT) operations under one integrated structure that reflects the global Samsung brand behind its technology.
The unification underscores Samsung’s continued strategic investment in advancing medical imaging innovation and strengthening its presence in the United States healthcare market. By aligning its brand structure with its expanding portfolio and growing U.S. footprint, Samsung reinforces its long-term commitment to delivering cutting-edge imaging solutions, deep clinical collaboration and sustained operational excellence.
“This milestone represents more than a name change,” said Kyu Tae Yoo, CEO of Samsung Medison and Division Head of Samsung HME at Samsung Electronics. “It reinforces Samsung’s long-term commitment to healthcare providers nationwide and reflects the growth and maturity of our U.S. medical imaging organization. Our growth has been powered by listening closely to our customers and translating real clinical challenges into innovation at a pace rarely seen in healthcare; and we will continue along this path."
The announcement follows a period of significant growth across Samsung’s U.S. medical imaging portfolio, marked by expanded product innovation, organizational investment, and deeper engagement with health systems nationwide. As demand for advanced imaging solutions continues to evolve, the company is scaling its U.S. presence to meet the needs of a rapidly transforming healthcare environment.
“This new chapter as Samsung HME America strengthens how we connect with customers and partners while giving us the flexibility to innovate and advance medical imaging for the future,” said Tracy Bury, Chief Commercial Officer. “With a unified organization, we can deliver greater consistency, deeper collaboration, and a more streamlined experience across ultrasound, digital radiography, and CT. This alignment positions us to move faster, support our partners more effectively, and continue building long-term relationships grounded in trust and performance”.
Recent advancements within Samsung HME America include the Samsung R20 and Z20 ultrasound systems, designed to deliver enhanced image quality and AI-powered tools that support more confident clinical decision-making. The company has also continued to expand its AI capabilities through the Samsung acquisition of Sonio, a French AI-powered prenatal ultrasound startup specializing in early-stage fetal abnormality detection. In addition, Samsung is advancing and expanding its Digital Radiography portfolio with innovations focused on dose reduction and workflow enhancements.
Samsung HME America remains the global headquarters and manufacturing center for the CT business, advancing point-of-care platforms and pushing the boundaries of medical imaging with photon counting detector technology.
The rebrand decision aligns with Samsung HME America’s mission of improving patient care by developing outstanding, customer-centric imaging solutions quickly and with passion. Under the newly established branding, the company looks to new AI technology releases, strategic partnerships, along with upcoming innovative product introductions into 2026.
For more information on Samsung medical imaging products and technology, please visit: https://usa.samsunghealthcare.com/.
September 17, 2026 
